Jianmin Pharmaceutical Group Co Ltd (600976) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.06 Million ≈ $12.89 Million USD) by net assets (CN¥2.60 Billion ≈ $380.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jianmin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jianmin Pharmaceutical Group Co Ltd (600976) financial obligations for a breakdown of total debt and financial obligations.
Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mediterranean Towers Ltd
TA:MDTR
|
0.025x |
|
Gerresheimer AG
F:GXI
|
0.042x |
|
Energisa Mato Grosso - Distribuidora de Energia S/A
SA:ENMT3
|
0.084x |
|
REVO INSURANCE SPA O.N.
F:H0O
|
N/A |
|
HELLOFRESH UNSP.ADS/025
F:HFG0
|
N/A |
|
Shenandoah Telecommunications Co
NASDAQ:SHEN
|
0.031x |
|
Alltop Technology Co Ltd
TWO:3526
|
0.099x |
|
LSI Industries Inc
NASDAQ:LYTS
|
0.101x |
Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Jianmin Pharmaceutical Group Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.45 Billion ≈ $358.56 Million |
CN¥234.27 Million ≈ $34.28 Million |
0.096x | -19.62% |
| 2023-12-31 | CN¥2.26 Billion ≈ $330.19 Million |
CN¥268.39 Million ≈ $39.27 Million |
0.119x | +2.92% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.32 Million |
CN¥215.87 Million ≈ $31.59 Million |
0.116x | -30.07% |
| 2021-12-31 | CN¥1.57 Billion ≈ $229.48 Million |
CN¥259.18 Million ≈ $37.93 Million |
0.165x | +74.20% |
| 2020-12-31 | CN¥1.32 Billion ≈ $193.63 Million |
CN¥125.54 Million ≈ $18.37 Million |
0.095x | +53.92% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
CN¥74.45 Million ≈ $10.89 Million |
0.062x | +10.97% |
| 2018-12-31 | CN¥1.15 Billion ≈ $167.56 Million |
CN¥63.60 Million ≈ $9.31 Million |
0.056x | +74.75% |
| 2017-12-31 | CN¥1.11 Billion ≈ $162.05 Million |
CN¥35.20 Million ≈ $5.15 Million |
0.032x | -71.21% |
| 2016-12-31 | CN¥1.03 Billion ≈ $150.92 Million |
CN¥113.84 Million ≈ $16.66 Million |
0.110x | +127.22% |
| 2015-12-31 | CN¥997.36 Million ≈ $145.94 Million |
CN¥48.45 Million ≈ $7.09 Million |
0.049x | -52.85% |
| 2014-12-31 | CN¥1.00 Billion ≈ $146.63 Million |
CN¥103.23 Million ≈ $15.11 Million |
0.103x | +113.60% |
| 2013-12-31 | CN¥940.46 Million ≈ $137.62 Million |
CN¥45.36 Million ≈ $6.64 Million |
0.048x | -55.63% |
| 2012-12-31 | CN¥903.10 Million ≈ $132.15 Million |
CN¥98.17 Million ≈ $14.37 Million |
0.109x | +226.20% |
| 2011-12-31 | CN¥876.97 Million ≈ $128.33 Million |
CN¥-75.54 Million ≈ $-11.05 Million |
-0.086x | -148.72% |
| 2010-12-31 | CN¥848.81 Million ≈ $124.21 Million |
CN¥150.08 Million ≈ $21.96 Million |
0.177x | +117.47% |
| 2009-12-31 | CN¥820.32 Million ≈ $120.04 Million |
CN¥66.69 Million ≈ $9.76 Million |
0.081x | -43.79% |
| 2008-12-31 | CN¥761.24 Million ≈ $111.39 Million |
CN¥110.11 Million ≈ $16.11 Million |
0.145x | +1660.69% |
| 2007-12-31 | CN¥742.63 Million ≈ $108.67 Million |
CN¥-6.88 Million ≈ $-1.01 Million |
-0.009x | -112.65% |
| 2006-12-31 | CN¥766.61 Million ≈ $112.18 Million |
CN¥56.18 Million ≈ $8.22 Million |
0.073x | +260.73% |
| 2005-12-31 | CN¥759.65 Million ≈ $111.16 Million |
CN¥-34.63 Million ≈ $-5.07 Million |
-0.046x | -877.87% |
| 2004-12-31 | CN¥705.12 Million ≈ $103.18 Million |
CN¥4.13 Million ≈ $604.74K |
0.006x | -59.37% |
| 2003-12-31 | CN¥290.32 Million ≈ $42.48 Million |
CN¥4.19 Million ≈ $612.80K |
0.014x | -- |
About Jianmin Pharmaceutical Group Co Ltd
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.